NOVAVITA THERA Trademark

Trademark Overview

On Thursday, October 22, 2020, a trademark application was filed for NOVAVITA THERA with the United States Patent and Trademark Office. The USPTO has given the NOVAVITA THERA trademark a serial number of 90271366. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 20, 2022. This trademark is owned by Cytotheryx, Inc.. The NOVAVITA THERA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

medical treatment, namely, administering gene therapies in the nature of in vivo and ex vivo vector treatments; medical treatment, namely, administering gene therapies in the nature of lentiviral vector therapies; medical treatment, namely, administering gene therapies in the nature of gene therapies for the treatment of rare diseases; medical treatment, namely, administering gene therapies in the nature of gene therapies for Hereditary Tyrosinemia Type 1; medical treatment, namely, administering gene therapies in the nature of gene therapies for orphan disease; medical treatment, namely, administering gene therapies in the nature of gene therapies for inborn errors of hepatic metabolism
novavita thera

General Information

Serial Number90271366
Word MarkNOVAVITA THERA
Filing DateThursday, October 22, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 20, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements

Translation of Words in MarkThe words "novavita thera" has no meaning in a foreign language.
Goods and Servicesmedical treatment, namely, administering gene therapies in the nature of in vivo and ex vivo vector treatments; medical treatment, namely, administering gene therapies in the nature of lentiviral vector therapies; medical treatment, namely, administering gene therapies in the nature of gene therapies for the treatment of rare diseases; medical treatment, namely, administering gene therapies in the nature of gene therapies for Hereditary Tyrosinemia Type 1; medical treatment, namely, administering gene therapies in the nature of gene therapies for orphan disease; medical treatment, namely, administering gene therapies in the nature of gene therapies for inborn errors of hepatic metabolism

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 10, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCytotheryx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRochester, MN 55903
Party NameCytotheryx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRochester, MN 55903

Trademark Events

Event DateEvent Description
Tuesday, June 21, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 20, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 20, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 20, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 19, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, August 19, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 19, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, August 19, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, August 19, 2021HIDDEN SENSITIVE CONTENT
Thursday, August 19, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, August 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 19, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, August 19, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 19, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, August 19, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, August 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 11, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 11, 2021NON-FINAL ACTION E-MAILED
Thursday, February 11, 2021NON-FINAL ACTION WRITTEN
Monday, February 1, 2021ASSIGNED TO EXAMINER
Thursday, December 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

thera novavita therapies gene treatment medical nature administering namely vector vivo inborn